FDA Inspection
Microvascular Tissue, IncMicrovascular Tissue, Inc – FDA Inspection, Apr 8, 2025
Record Details
This FDA Inspection record concerns Microvascular Tissue, Inc, with an inspection on April 8, 2025, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 3300ecef-3ed9-4dba-ad72-c49b9a900884
Inspection Facts
- Inspection number
- 1266729
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Microvascular Tissue, Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Microvascular Tissue, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.